British doc calls for boys to get HPV vaccines; Dendreon receives EU approval boost;

> A leading British doctor has called for boys to receive HPV vaccines. Article

> Dendreon ($DNDN) has received approval to market Provenge in Europe. News

> The NYT has taken a closer look at last week's preclinical HIV vaccine success. Feature (sub. req.)

> Genocea has reported positive interim data from a trial of its herpes vaccine. Item

> Profectus BioSciences has begun a Phase I clinical trial of its HIV vaccine. Article

> A Cleveland Clinic spinout has raised cash to advance a breast cancer vaccine into the clinic. Piece

> Bangladesh has doubled its vaccine storage capacity ahead of introducing a pneumococcal shot. Item

> Panacea Biotec has reportedly received WHO prequalification for its pentavalent vaccine. News

And Finally... The Indian Academy of Pediatrics has defended the safety of the pentavalent vaccine. Piece

Suggested Articles

Novavax will have billions of doses of COVID-19 vaccine capacity next year and could single-handedly meet U.S. demand, executives said.

As top players race to deliver COVID-19 vaccines, Russia approved a locally developed shot based on skimpy data. Experts called it a political stunt.

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan